TIDMAMS

RNS Number : 6657C

Advanced Medical Solutions Grp PLC

21 January 2015

21 January 2015

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Notice of Preliminary Results

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the surgical and advanced woundcare specialist company, will announce its unaudited preliminary results for the year ended 31 December 2014 on Wednesday 4 March 2015.

A briefing for analysts will be held at 10:00am on the day of the results. Please contact Consilium Strategic Communications for further details.

- Ends -

For further information, please visit www.admedsol.com or contact:

 
Advanced Medical Solutions Group plc 
 Chris Meredith, Chief Executive Officer 
 Mary Tavener, Group Finance Director                                   +44 (0) 1606 545508 
Consilium Strategic Communications                                     +44 (0) 20 3709 5700 
 Mary-Jane Elliot / Jonathan Birt / Matthew Neal / Ivar Milligan    AMS@consilium-comms.com 
Investec Bank plc (NOMAD & Broker) 
 Gary Clarence / Daniel Adams / Patrick Robb                           +44 (0) 20 7597 5970

About Advanced Medical Solutions Group plc - see www.admedsol.com

Founded in 1991, AMS is a leader in the development and manufacture of innovative and technologically advanced products for the US$20 billion global wound care and wound closure market. AMS has a wide range of products based on technologies that include alginates, silver alginates, foams, collagens, cyanoacrylate adhesives and sutures.

AMS manufactures wound care products for an extensive list of Original Equipment Manufacturer ("OEM") customers around the world, but the majority of the Group's revenues now come from its own brands - ActivHeal(R) wound care products in the UK to the NHS, LiquiBand(R) cyanoacrylate products primarily in the UK, Europe and the USA, and RESORBA(R) sutures and haemostat products primarily in Europe. AMS develops innovative products from its R&D pipeline which it commercialises globally, either directly or through partnerships with its OEM customers.

AMS's products are sold globally via a network of regional or multinational partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.

With 465 employees operating under four distinct business units (Branded Direct, Branded Distributed, OEM and Bulk Materials) that match its multiple products and routes-to-market, AMS's products are manufactured from two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOREASFEAFKSEFF

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.